Cognito Reports Pivotal Phase 3 Results for Spectris AD, a Non-Invasive, At-Home Approach for Alzheimer's Treatment, Backed by ADDF Investme
Study misses primary endpoint, but prespecified analysis suggests possible benefit in mild Alzheimer
Study misses primary endpoint, but prespecified analysis suggests possible benefit in mild Alzheimer